I-131-CLR1404
DCL-14-002
Phase 1 small_molecule completed
Quick answer
I-131-CLR1404 for Multiple Myeloma is a Phase 1 program (small_molecule) at Cellectar Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cellectar Biosciences
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed